Towards medicines regulatory authorities' quality performance improvement: value for public health
Article first published online: 2 JUL 2014
Copyright © 2014 John Wiley & Sons, Ltd.
The International Journal of Health Planning and Management
How to Cite
2014), Towards medicines regulatory authorities' quality performance improvement: value for public health, The International Journal of Health Planning and Management. doi: 10.1002/hpm.2265and (
- Article first published online: 2 JUL 2014
- Manuscript Accepted: 30 MAY 2014
- Manuscript Revised: 21 MAY 2014
- Manuscript Received: 5 SEP 2012
- medicines regulatory authority;
- public health;
- generic TQM model;
- public organisations
The purpose of this article is to explore the possibility of implementing total quality management (TQM) principles in national medicines regulatory authorities in Europe to achieve all public health objectives. Bearing in mind that medicines regulation is a governmental function that serves societal objectives to protect and promote public health, measuring the effective achievement of quality objectives related to public health is of utmost importance. A generic TQM model for meeting public health objectives was developed and was tested on 10 European national medicines regulatory authorities with different regulatory performances. Participating national medicines regulatory authorities recognised all TQM factors of the proposed model in implemented systems with different degrees of understanding. An analysis of responses was performed within the framework of two established criteria—the regulatory authority's category and size. The value of the paper is twofold. First, the new generic TQM model proposes to integrate four public health objectives with six TQM factors. Second, national medicines regulatory authorities were analysed as public organisations and health authorities to develop a proper tool for assessing their regulatory performance. The paper emphasises the importance of designing an adequate approach to performance measurement of quality management systems in medicines regulatory authorities that will support their public service missions. Copyright © 2014 John Wiley & Sons, Ltd.